Jump to content

STAT inhibitors

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Entranced98 (talk | contribs) at 20:43, 10 February 2023 (Importing Wikidata short description: "Drug class"). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

STAT inhibitors are drugs which target signal transducer and activator of transcription (STAT) proteins, a family of cytoplasmic induction factors. Inhibitors of STAT proteins are being developed for use in cancer therapy.[1]

See also

References

  1. ^ Furqan, Muhammad; Akinleye, Akintunde; Mukhi, Nikhil; Mittal, Varun; Chen, Yamei; Liu, Delong (2013-12-05). "STAT inhibitors for cancer therapy". Journal of Hematology & Oncology. 6: 90. doi:10.1186/1756-8722-6-90. ISSN 1756-8722. PMC 4029528. PMID 24308725.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=STAT_inhibitors&oldid=1138649462"